Correlation of blood high mobility group box-1 protein with mortality of patients with sepsis: A meta-analysis

Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study

(2020) Kristina E Rudd et al.   LANCET

Prediction of mortality in adult patients with sepsis using six biomarkers: a systematic review and meta-analysis

(2019) Andreas Pregernig et al.   Annals of Intensive Care

High mobility group box 1 as a biomarker in critically ill patients

(2018) Eray Yagmur et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Sepsis 2018: Definitions and Guideline Changes

(2018) Lena M. Napolitano   Surgical Infections

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

(2016) Mervyn Singer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

HMGB1 as biomarker and drug target

(2016) Emilie Venereau et al.   PHARMACOLOGICAL RESEARCH

Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range

(2016) Dehui Luo et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Associations between Single Nucleotide Polymorphisms of High Mobility Group Box 1 Protein and Clinical Outcomes in Korean Sepsis Patients

(2016) Kwangha Lee et al.   YONSEI MEDICAL JOURNAL

sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock

(2015) Cecilia Gómez Ravetti et al.   JOURNAL OF CRITICAL CARE

Expression of HMGB1 in septic serum induces vascular endothelial hyperpermeability

(2015) YUN-JIANG ZHENG et al.   Molecular Medicine Reports

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

(2015) Xiang Wan et al.   BMC Medical Research Methodology

High HMGB1 level is associated with poor outcome of septicemic melioidosis

(2014) Jaruek Charoensup et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Assessing Bias in Studies of Prognostic Factors

(2013) Jill A. Hayden et al.   ANNALS OF INTERNAL MEDICINE

Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis

(2012) Rodrigo M Narvaez-Rivera et al.   BMC INFECTIOUS DISEASES

New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis

(2010) S. Gaïni et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

HMGB-1 as a Useful Prognostic Biomarker in Sepsis-Induced Organ Failure in Patients Undergoing PMX-DHP

(2009) Takuya Ueno et al.   JOURNAL OF SURGICAL RESEARCH

HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis

(2008) Sari Karlsson et al.   INTENSIVE CARE MEDICINE